Skip to Main Content

Paper Details

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines.
274
2021
B.1.1.7, COVID-19, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 spike, mRNA, spike, spike mutations
Author NameAffiliation
Xiaoying ShenDuke University School of Medicine, USA Duke Human Vaccine Institute
Barton F HaynesDuke Human Vaccine Institute, Duke University School of Medicine, Duke University Medical Center
Nicolas W HengartnerLos Alamos National Laboratory
Bette KorberLos Alamos National Laboratory
David C MontefioriDuke University School of Medicine, USA Duke Human Vaccine Institute
  • 1 - 5

Datasets

Release 1.2